
Deep Breath (Cannabis flos Canopy Growth): a myrcene strain with no established lineage
Deep Breath is a position from Spectrum Therapeutics, for which none of the Polish databases provide parents. We gathered what one source says about its composition, what has not been demonstrated about myrcene, and why we do not record the declared potency here.
| Strain Card | Deep Breath |
|---|---|
| Producers | Canopy Growth (1 pharmacy position) |
| Medical Brand | the same as the producer |
| Alternative Names | none |
| Category by Sources | hybrid / sativa (sources inconsistent) |
| Leading Terpene | myrcene |
| Other Terpenes | limonene pinene |
| Lineage | unknown |
| Source Consistency | one source |
- Who supplies it. Exclusively Canopy Growth, so there is nothing to compare versions with, and a supply break means this strain is unavailable, not another version of it.
- Profile. It leads with myrcene, alongside limonene and pinene. We do not provide percentage shares because sources count them against different totals.
- Origin. Lineage is unknown. This is a result, not a gap to fill: we do not assign parents based on name similarity.
- What is missing. The profile describes one source, so there is nothing to compare it with.
What is Deep Breath and where does this strain come from?
The lineage of this strain remains unknown: neither of the two Polish databases describing it provide parents, and the breeder has never announced them. It reaches pharmacies as Spectrum Therapeutics flower, a medical brand of Canopy Growth, and under a registered name that describes the raw material, not a genetically confirmed breeding line.
The lack of lineage is an answer here, not a gap in our data. In this cluster, twenty-five out of eighty-five entries have no established origin, and Deep Breath belongs to this group. Assigning parents by intuition, based on the sound of the name or aroma similarity, creates connections in the lineage graph that no one has confirmed, and these then return as facts cited by subsequent pages.
The discrepancy even extends to the basic label. One database describes Deep Breath as a sativa strain, while another as a hybrid, so even this simplest division is not agreed upon in Polish listings. The label itself resolves little: it speaks to the plant’s growth form, not how a specific batch of flower will behave in a specific patient.
The registered name ties this strain to a history not visible on the packaging. Deep Breath appears in Polish listings under the same registered name as a previous Canopy Growth entry, and one database describes it directly as a successor to the strain Original Gangster Deluxe. The cultivar behind the name has changed, but the prescription remains the same.
Which producers supply Deep Breath to Polish pharmacies?
One. In the Polish inventory, this strain appears exclusively as Canopy Growth flower under the Spectrum Therapeutics brand, in one position, so there is no competitive version to compare it with. The only sensible comparison goes back to the entry that was previously issued under the same registered name and which Deep Breath has replaced in listings.
| Position | Producer | How it differs in listings | Status according to the database |
|---|---|---|---|
| Deep Breath | Spectrum Therapeutics, medical brand of Canopy Growth | profile with limonene, myrcene, and pinene, provided by one database; genetics described inconsistently | availability marked as none |
| Original Gangster Deluxe | Canopy Growth | same registered name, different cultivar, terpinolene leading the profile and described parents | position replaced by Deep Breath |
One position in the inventory means for the patient that there is nothing to choose between producers: either it is available, or it is not. The pharmacy dispenses the raw material under the registered name, and this can be more durable than the commercial name of the cultivar, so under an unchanged prescription, a different plant can appear than during the previous fulfillment.
The declared potency is not recorded in this text at all. The producer provides one number, and their declaration allows for a deviation of up to one-tenth of the value, so an honest record is a range. For this position, none of the tolerance listings provide, and the range cannot be counted as the producer’s and signed with their name.
Availability changes for reasons that the raw material itself cannot influence. The permit for admission expires and can be revoked, delivery can be delayed, and the wholesaler distributes the batch unevenly among pharmacies. One database currently marks Deep Breath as unavailable, which is a snapshot of the state from a specific day, not a permanent feature of the strain. We maintain a current overview of what is actually available in the list of available strains, along with numbers that change from month to month. The entire portfolio of the producer is described separately.
What does Deep Breath smell and taste like?
The aroma description comes from one database and boils down to three terms: fruity, fuel-like, and vanilla. The terpene composition adds a resinous-citrus accent, as alongside myrcene, limonene is indicated. This is an editorial description, not a result of sensory analysis conducted for a specific batch of flower.
The terpene composition of this strain is provided by one source, the database budcare.pl, and it lists limonene, myrcene, and pinene. The second database describing this position does not provide the order of terpenes at all, so there is nothing to confirm this composition or compare it with. We do not record percentage shares with these names because the denominator is different in each listing. Summing what the databases provide for one position, we arrived at eighty-three percent; for the second, seventy-three, and for the third, barely forty-six. The number next to the terpene name thus appears to be a measurement, but is a fraction of the whole, which no one has defined.
Olfactorily, each of these three compounds pulls in its own direction. Limonene is responsible for the citrus note, pinene for the resinous and pine-like, and myrcene for earthy, herbal, and slightly fruity. The descriptions from the database can be reconciled with this, although they do not directly result from it: the fuel-like note is often described in many contemporary hybrids regardless of which terpene leads the profile.
The aroma does not predict effects and is not stable. Terpenes are volatile, so an open package loses some scent over weeks, and drying and storage can shift the character of a batch more than the difference between two cultivars. The vapor from the vaporizer smells differently than the crushed flower, as individual compounds transition into it at different rates.
How long does it take for Deep Breath to take effect and how long does the effect last?
This is determined by the route of administration, not the strain name. For no single cultivar has pharmacokinetic measurement been published, so the ranges below describe the behavior of cannabis flower as a raw material administered by inhalation or orally, and that is all that can be said honestly about the onset time of this position today.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, because pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After swallowing | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Onset | another ten to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
The leading terpene of this route does not shift. Myrcene is often presented in popular descriptions as a factor enhancing drowsiness, but in studies that have checked this, it was administered to animals separately, without flower and without the other components of the plant.
What is known and what is not known about the effects of Deep Breath?
Nothing has been demonstrated for Deep Breath itself. There is no study in which this strain was administered to patients and the outcome measured, so public material is divided into studies on individual terpenes conducted on rodents, and descriptions from strain databases and patient reports, which are not studies.
Myrcene has been indicated for this strain as the leading terpene, so it is him that three studies collected in our evidence base concern. All three were conducted on mice, none pertains to flower or patients, and the outcome in them depends on the route of administration and the sex of the animals.
| Study | Model and route of administration | What was demonstrated |
|---|---|---|
| Rao VS et al., 1990 Journal of Pharmacy and Pharmacology PMID:1983154 |
rodent (mouse) | Myrcene (10-40 mg/kg) reduced pain responses in mice in hot plate and writhing tests induced by acetic acid; the effect was reversed by naloxone and yohimbine, indicating involvement of alpha2-adrenergic receptors and release of endogenous opioids. |
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Myrcene administered intraperitoneally (100-200 mg/kg) reduced the locomotor activity of mice in the open field test, prolonged sleep induced by pentobarbital (by about 2.6 times at 200 mg/kg), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic. |
| Wagner JK et al., 2024 NeuroSci PMID:39728677 |
rodent (mouse, vapor pairs) | With short puffs mimicking inhalation in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single puff. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. |
In humans, it has not been demonstrated that myrcene alone alleviates insomnia at doses typical for inhalation of flower. The direction of the effect in rodents depends on the route of administration and sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, and after inhalation in 2024, an anxiolytic effect in females. These two results do not negate each other, they only show that the conclusion depends on conditions that no popular strain database provides.
On the other side stands material that is not a study: descriptions in strain databases, the producer’s card, and patient reports. Databases repeat the same terms, and for this position, they also add the suggestion that it is intended for individuals with prior experience, not for those starting therapy. This is a commercial hint based on declared potency, not a result of measurement in patients, and the choice of raw material is determined by the attending physician, not the description in the database.
What side effects have been reported after Deep Breath?
None that could be attributed to this strain. Safety monitoring is conducted for the medicinal product identified by the batch number, not for the commercial name of the cultivar, so a report from a patient or pharmacy never enters the collection described by the name Deep Breath, and such a collection cannot be read.
Reports of adverse effects are collected for the medicinal product with a batch number, not for the strain name, so the following pertains to cannabis flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety increasing with dosage. A separate matter is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not the description of the plant. We do not provide the frequency of these symptoms numerically, as public listings for cannabis flower in Poland do not separate them by individual products.
The lack of separate statistics does not mean that this strain is milder than others. It means that no one is maintaining a collection under its name, so any statement about its safety profile would be guesswork. Symptoms are reported to the attending physician regardless of what commercial name is on the package.
What do the boiling points of terpenes say about vaporizing Deep Breath?
Less than popular tables promise. The three terpenes indicated for this strain boil at atmospheric pressure at different temperatures: pinene around 156 degrees Celsius, myrcene around 167, limonene around 178. None of these numbers is a threshold below which a given compound ceases to evaporate.
All three values come from the public database PubChem and were read at the same pressure, 760 millimeters of mercury, so they can be compared with each other. Not every terpene has such a record in this database: for some entries, measurements were provided at reduced pressure, and such a number cannot be added to one table with the others.
Evaporation begins long before these values are reached, and its rate increases exponentially with temperature. Boiling occurs only where the vapor pressure equals the surrounding pressure, and this one situation is described by the number in the table. The popular targeting of a specific terpene by setting the equipment to its boiling temperature arises precisely from confusing these two things, which we break down in separate parts.
The second thing that these tables do not say is what the number on the display actually represents. The setting describes the temperature of the heating element or air, not the flower itself, which cools with the airflow during inhalation and heats unevenly. The difference between one value and the other exists and has not been publicly measured, so we do not provide any recommended range here. The method of administering the raw material is determined by the attending physician, and the flower itself is dispensed according to the physician’s prescription.
Which strains are related to Deep Breath?
None. Without established parents, it is impossible to indicate siblings, and the list of related positions is empty for this strain and remains so. An empty result is an answer here, not a gap to fill at the next opportunity: adding a relative without a source creates a connection that no one has confirmed.
Kinship is counted solely by common, named parents. It is not created by a common producer or the same leading terpene, although in the Spectrum Therapeutics catalog, there would be positions meeting both conditions at once. Afghan Kush has exactly the same status as Deep Breath: myrcene leading the profile and an origin that no one has established. This is a coincidence of two empty fields, not family.
Even if the breeder were to reveal parents someday, siblings would not automatically appear. A wide family style, such as afghani or haze, is often given as a parent, and these are categories that cannot be indicated as single plants. Two strains sharing only such an ancestor do not become siblings because of that, and in our graph, there is no edge between them.
In neighboring entries from the same catalog, the lineage is sometimes described. Ultra Jack has listed parents, as does White Widow X, and it is precisely there that the lineage graph has something to hold onto. With Deep Breath, there is not even a starting point, so the strain remains in the cluster as a node without edges, connected to the rest solely through the producer and the leading terpene.
Frequently Asked Questions about the Deep Breath strain
Is Deep Breath a sativa or a hybrid?
It depends on which database you open. One describes this position as a sativa, another as a hybrid, and neither provides parents on which this division could be based. The label itself does not predict how a specific batch of flower will act.
Who supplies Deep Breath to Polish pharmacies?
Spectrum Therapeutics, the medical brand of Canopy Growth. In the Polish inventory, this is the only position with this name, so there is no alternative version or second producer to compare it with.
Why is there no THC content in this text?
Because the source provides one number and does not provide tolerance. The producer’s declaration allows for a deviation of up to one-tenth of the value, so an honest record is a range, and the range cannot be counted as the producer’s.
Does Deep Breath have a documented lineage?
No. Neither of the two Polish databases provides its parents, and the breeder has not announced them. In this cluster, twenty-five strains out of eighty-five have this status, and it is information, not a lack of data to fill in.
Is Deep Breath available in pharmacies?
Availability changes from month to month, and one database currently marks this position as unavailable. The status of prescription fulfillment depends on permits and deliveries, not the strain itself, so it is checked in the pharmacy or in the current strain listing.
How does Deep Breath differ from Original Gangster Deluxe?
It is a different cultivar issued under the same registered name. Original Gangster Deluxe has described parents and terpinolene leading the profile, while Deep Breath has no established origin and myrcene has been indicated for it.
Cannabis flower is a pharmaceutical raw material dispensed by a physician’s prescription in the Rpw category, and its advertising directed to the public is prohibited. The material is informational in nature, describes the state of evidence, and does not replace consultation with the attending physician. Over-the-counter cannabis flower is a different category of products than the raw material described above. Editorial text: editorial team ubucha.pl.







